Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
105.4 USD | -0.86% | -1.31% | -4.19% |
04-29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
04-26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Analyst Reco.